ARCA Biopharma Inc (NASDAQ:ABIO)

1.65
Delayed Data
As of Feb 16
 +0.005 / +0.30%
Today’s Change
1.05
Today|||52-Week Range
2.76
+22.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-6.9M-9.7M-11.4M-16.4M
 
 
 
 
 
Depreciation26.0K12.0K19.0K24.0K
 
 
 
 
 
Total Other Cash Flow283.0K714.0K788.0K1.0M
 
 
 
 
 
Funds From Operations-6.6M-9.0M-10.6M-15.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.3M443.0K-104.0K-400.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-5.3M-9.4M-10.5M-15.0M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-20.5M
 
 
Decrease In Investments0.000.000.004.1M
 
 
Capital Expenditures-32.0K-19.0K-11.0K-12.0K
 
 
 
 
 
Net Cash Flow Investing-32.0K-19.0K-11.0K-16.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.00--0.00--
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction-174.0K0.000.00--
 
 
Net Proceeds Stock Sale19.3M8.2M34.2M0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.00179.0K193.0K0.00
 
 
 
Net Cash Flow - Financing19.2M8.0M34.0M0.00
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.000.00------
 
Net Change In Cash13.8M-1.4M23.4M-31.4M